Use of stem cells in the treatment of individuals with Autism Spectrum Disorder - Integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v13i3.45328

Keywords:

Stem cells; Autistic spectrum; Stem cell therapy.

Abstract

Autism Spectrum Disorder (ASD) is associated with multifactorial causes - genetic and environmental, such as prematurity, asphyxia and fetal exposure to alcohol and drugs. Studies indicate that genes such as NLGN4 and ASTN2 are associated with autism. Treatments are divided into behavioral, nutritional and medicinal approaches, but new findings in epigenetics and neuroimmunology suggest that hematopoietic stem cell therapies may be potential interventions for the treatment of autistic syndromes. The aim of this study was to carry out an integrative review on the use of stem cells in the therapy of individuals with autistic spectrum disorders. PubMed, Scielo, Google Scholar and Adolec databases were used, with articles published between 2010 and 2021. The PICo (Population, Phenomenon, Context) strategy was used to define the research question. Stem cells are unspecialized precursor cells that have the ability to self-renew, the ability to differentiate and the ability to reconstitute. However, the problem is how a new treatment using this therapy can influence the improvement of individuals with ASD, which is identified by observing the influence of transplanting these cells into humans on their motor and cognitive skills. The etiology of autism in the studies is indicated in the involvement of immunological dysregulations, but its pathophysiology remains poorly defined and the exact mechanisms of transplantation have yet to be confirmed and clarified, which suggests further studies in order to verify the effectiveness of this therapeutic approach in the long term.

References

Brasil. (2015). Espectro Autista (Transtornos Invasivos ou Globais do Desenvolvimento): Protocolo Clínico e de Acolhimento. Sistema Único de Saúde, Estado de Santa Catarina. https://www.saude.sc.gov.br/index.php/documentos/atencao-basica/saude-mental/protocolos-da-raps/9209-espectro-autista/file.

Evangelho, V. G. O., Costa, F. M. R., Castro, H. C., Bello, M. L. & Amorim, M. R. (2021). Autismo no Brasil: uma revisão sobre estudos em neurogenética. Revista Neurociências. 29, 1-20. https://doi.org/10.34024/rnc.2021.v29.12440.

Fogo, M. S. (2018). Estudo de expressão gênica em células neurais derivadas de células-tronco pluripotentes induzidas de indivíduos com Transtorno do Espectro Autista. Tese de Doutorado, Universidade de São Paulo. https://www.teses.usp.br/teses/disponiveis/41/41131/tde-13122018-083852/publico/Mariana_Fogo_SIMPL.pdf.

Lv, Y., Zhang, Y.,Liu, M.,Qiuwaxi, J., Ashwood, P., Cho, S. C., Huan, Y., Ge, R., Chen, X., Wang, Z., Kim, B. & Hu, X. (2013). Transplante de células mononucleares do cordão umbilical e células-tronco mesenquimais derivadas do cordão umbilical no autismo. Journal of Translational Medicine. 11 (196). https://doi.org/10.1590/S1516-84842009005000057

Muotri, A. R. (2010) Células-tronco pluripotentes e doenças neurológicas. Estudos Avançados, 24(70), 71-79. https://doi.org/10.1590/S0103-40142010000300005

Pavin, N., Sguarezi, O. G. M. & Batista, E. C. (2019). Novas abordagens etiológicas do transtorno do espectro autista. Saúde & Conhecimento-Jornal de Medicina Univag. https://periodicos.univag.com.br/index.php/jornaldemedicina/article/view/1433/1591.

Queiroz, L. S. & Mendes, N. B. E. S. (2017) O transtorno do espectro autista e a terapêutica com células tronco. CES REVISTA, 1(1). https://seer.uniacademia.edu.br/index.php/cesRevista/article/viewFile/1138/782.

Riordan, N. H., Hincapié, M. L., Morales, I., Fernández, G., Allen, N., Leu, C., Madrigal, M., Rodríguez, J. P. & Novarro, N. (2019). Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels. Stem Cells Translational Medicine, v. 8, p. 1008–1016. 10.1002/sctm.19-0010.

Russo, F. B. (2015). Geração de células pluripotentes induzidas de pacientes com transtorno do espectro autista. Tese de Doutorado, Universidade de São Paulo. 99p. https://doi.org/10.11606/T.10.2016.tde-14082015-154556

Sampaio, G. L. A. (2019). Geração de linhagens de células tronco pluripotente induzidas com alteração no gene SCN2A e organoides cerebrais como ferramenta para estudo do autismo. Dissertação de Mestrado, Instituto Gonçalo Moniz, Salvador, Bahia. 81p. https://www.arca.fiocruz.br/handle/icict/36148.

Sharma, A. K., GOkulchandran, N., Kulkarni, P. P., Sane, H. M., Sharma, R., Jose, A. & Badhe, P. B. (2020) Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study. Am J Stem Cells, 9, (5), 89-100. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811933

Simioni, P. U., Santos, H. M. & Ugrinovich, L. A. (2021). Aplicação das células-tronco pluripotentes induzidas na investigação do autismo: uma revisão. Jorn. Inter. Bioc., 6, (1), 24-28.https://faculdadedeamericana.com.br/ojs/index.php/TCC/article/view/377/634

Siniscalco, D., Kannan, S., Semprún-hernández, N., Eshraghi, A. A., Brigida, A. L. & Antonucci, N. (2018) Stem cell therapy in autism: recent insights. Stem Cells and Cloning: Advances and Applications, 11, 55–67. 10.2147/SCCAA.S155410.

Published

24/03/2024

How to Cite

PADILHA, E. O. .; GONÇALVES, M. de F. V. de S. .; LARANJEIRA, I. G. .; IARGAS, G. O. .; VELASCO, B. A. .; VICENTINI, J. R. .; SAKAMOTO, S. R. . Use of stem cells in the treatment of individuals with Autism Spectrum Disorder - Integrative review. Research, Society and Development, [S. l.], v. 13, n. 3, p. e9513345328, 2024. DOI: 10.33448/rsd-v13i3.45328. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/45328. Acesso em: 25 jun. 2024.

Issue

Section

Health Sciences